Stage migration with sentinel node biopsy in breast cancer

American Journal of Surgery

Volumn 197, Issue 4, 2009, Pages 491-496

  Layeequr Rahman, Rakhshanda ^a   Siegel, Eric ^a   Boneti, Cristiano ^a   Ingram, Malene ^a   Kepple, Julie ^a   Henry Tillman, Ronda S ^a   Klimberg, V Suzanne ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast cancer; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

AGED; AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 62949220008     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.07.052     Document Type: Article

References (27)

1. Quiet C.A., Ferguson D.J., Weichselbaum R.R., et al. Natural history of node-negative breast cancer: a study of 826 patients with long term follow up. J Clin Oncol 13 (1995) 1144-1151
2. Carter C.L., Allen C., and Hensen D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
3. Fisher E.R., Sass R., and Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). Cancer 53 (1984) 712-723
4. Schwartz G.F., Guiliano A.E., and Veronesi U. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J 8 (2002) 124-138
5. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and of limited nodal dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
6. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
7. Giuliano A.E., Jones R.C., Brennan M., et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 (1997) 2345-2350
8. Layeeque R., Henry-Tillman R.S., Korourian S., et al. Subareolar sentinel node staging for multiple breast cancers. Am J Surg 186 (2003) 730-736
9. White R.L., and Wilke L.G. Update on the NSABP and ACOSOG sentinel node trials. Am Surg 70 (2004) 420-424
10. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and of limited nodal dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
11. Schwartz G.F., Giuliano A.E., Veronesi U., and Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Breast J 8 (2002) 126-138
12. Fraile M., Rull M., Julian F.J., et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 1196 (2000) 701-705
13. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node negative breast cancer. J Clin Oncol 18 (2000) 2553-2559
14. Veronesi U., Galimberti V., Zurrida S., et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 37 (2001) 454-458
15. Roumen R.M.H., Kujit G.P., Liem I.H., et al. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88 (2001) 1639-1643
16. Schrenk P., Hatzl-Griesenhofer M., Shamiyeh A., et al. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 77 (2001) 165-170
17. Chung M.A., Steinhoff M.M., and Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 184 (2002) 310-314
18. Badgewell B.D., Povoski S.P., Abdessalam S.F., et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10 (2003) 376-380
19. Reitsamer R., Peintinger F., Prokop E., et al. Sentinel lymph node biopsy alone without axillary lymph node dissection-follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29 (2003) 221-223
20. Reitsamer R., Peintinger F., Prokop E., et al. 200 Sentinel lymph node biopsies without axillary lymph node dissection-no axillary recurrences after a 3-year follow-up. Br J Cancer 90 (2004) 1551-1554
21. Fisher B., Jong-Hyeon J., Stewart A., et al. Twenty five year follow up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 347 (2002) 567-575
22. Early Breast Cancer Trialists Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 352 (1998) 930-942
23. Cronin M., Sangli C., Liu M.L., et al. Analytical validation of Oncotype Dx genomic diagnostic test for recurrence, prognosis and therapeutic response prediction in node negative, estrogen receptor positive breast cancer. Clin Chem 53 (2007) 1084-1091
24. Bontenbal M., Nortier J.W.R., Beex L.V.A.M., et al. Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology. Ned Tijdschr Geneeskd 144 (2000) 984-989
25. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Adjuvant systemic therapy for women with node-negative breast cancer. CMAJ 158 Suppl (1998) S43-S51
26. Krag D.N., and Single R.M. Breast cancer survival according to the number of lymph nodes. Ann Surg Oncol 10 (2003) 1152-1159
27. McMasters K. The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer. Ann Surg Oncol 10 (2003) 1128-1130